Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.160
-0.020 (-1.69%)
Nov 18, 2026, 1:36 PM EST - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $51.65 million as of November 18, 2026. It is the 29,513th most valuable company in the world and the 4,522nd biggest in the United States. Its market cap has decreased by 49.46% in one year.
Market Cap
51.65M
Enterprise Value
40.63M
1-Year Change
-49.46%
Global Rank
Country Rank
#4,522 United States
Category
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $51.65M, a decrease of -58.56%. That is a compound annual growth rate of -14.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 51.65M | -58.30% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 54.27M |
| Verrica Pharmaceuticals | 53.94M |
| Nordicus Partners | 53.83M |
| Heron Therapeutics | 53.70M |
| Impact BioMedical | 53.31M |
| Xilio Therapeutics | 53.26M |
| Spero Therapeutics | 52.49M |
| Azora Therapeutics | 52.36M |